Cardiometabolic Health Congress

JANUARY 15, 2025

This imbalance is partly due to limited healthcare access, fewer preventive resources, and challenges in addressing risk factors such as obesity and diabetes. Enhancing Adherence: Simplify treatment plans and build trust through patient education. Improving Access: Advocate for equitable healthcare resources worldwide.

Atherosclerosis 59

Atherosclerosis Plaque Myocardial Infarction Risk Factors 59

Stroke Journal

JANUARY 30, 2025

Background:Lower educational attainment (EA) and smaller social network are each associated with a greater risk for incident stroke. In fully adjusted models, Mexican-American ethnicity, diabetes, and high cholesterol were associated with higher recurrence. Stroke, Volume 56, Issue Suppl_1 , Page ATP276-ATP276, February 1, 2025.

Education 40

Education Stroke Strokes Cholesterol 40

Journal of the American Heart Association

DECEMBER 8, 2023

Participants with BP assessments across 20 years and untreated BP of <130/80 mm Hg were included.

Blood Pressure 45

Blood Pressure Cholesterol Education Diabetes 45

DAIC

MAY 16, 2024

Risk factors for PAD include smoking; having Type 1 or Type 2 diabetes, high blood pressure, high cholesterol, chronic kidney disease, atherosclerosis in other parts of the body (such as coronary artery disease); and being age 75 years or older. and Global Data From the American Heart Association. Black adults with PAD in the U.S.

Peripheral Arterial Disease 105

Peripheral Arterial Disease Exercise Ischemia Quality of Life 105

Journal of the American Heart Association

FEBRUARY 19, 2025

Socioeconomic status (SES) was measured on the basis of income and education. Targeted interventions reducing the prevalence of smoking, diabetes, hypertension, and high cholesterol in patients with low SES could mitigate these disparities.

Stroke 40

Stroke Strokes Outcomes Atrial Fibrillation 40

Stroke Journal

JANUARY 30, 2025

When adjusted for age, sex, race/ethnicity, education and PIR, the mean LE8 score was significantly lower in those who reported a history of stroke at (59.2, 95% CI, 57.8-60.5) compared to those who did not (63.8, 95% CI, 63.4-64.2) in those who did not.

Stroke 40

Stroke Strokes Blood Pressure Diet 40

Stroke Journal

JANUARY 30, 2025

When adjusted for age, sex, race/ethnicity, education and PIR, the mean LE8 score was significantly lower in those who reported a history of stroke at (59.2, 95% CI, 57.8-60.5) compared to those who did not (63.8, 95% CI, 63.4-64.2) in those who did not.

Stroke 40

Stroke Strokes Blood Pressure Diet 40

Journal of the American Heart Association

JANUARY 31, 2024

The model adjusted for age, sex, body mass index, smoking, hypertension, diabetes, low‐density lipoprotein cholesterol, estimated glomerular filtration rate, education, and physical activity at baseline. We first identified baseline lipid species associated with risk of CHD, followed by replication in a European population.

Heart Disease 45

Heart Disease Risk Factors Cholesterol Education 45

Journal of the American Heart Association

DECEMBER 29, 2023

Education‐adjusted cut points were used to define suspected MCI. 1.38]) was also significantly associated with suspected MCI, after adjusting for age, sex, education level, mean arterial pressure, hypertension, diabetes, low‐density lipoprotein cholesterol, and smoking status. men; age range, 35–96 years [mean±SD, 59.9±11.8 years])

Aortic 40

Aortic Education Cholesterol Biomarkers 40

DAIC

OCTOBER 23, 2024

23, 2024 – The Society for Vascular Surgery (SVS) is launching a three-year patient education campaign, Highway to Health, to empower Americans to learn their SVS Strong Vessel Score and start a conversation with their doctor to see if a vascular surgeon could be a good addition to their overall care team.

Peripheral Arterial Disease 40

Peripheral Arterial Disease Quality of Life Education Risk Factors 40

Dr. Malcolm Kendrick

JANUARY 12, 2023

A key opinion leader can be critically important in helping to educate physicians about a new drug. Try publishing a paper suggesting that cholesterol lowering is a waste of time, when the market for cholesterol lowering drugs is worth hundreds of billions. Primarily because new ideas threaten profit. So, good luck with that.

Research 52

Research Cancer Innovation Article 52